Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin Duration for SSI Prevention in Third Molar Surgery
NCT06368102Phase 4Completed
- Sponsor
- Uji Takeda Hospital
- Start
- May 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ampicillin in surgical site infection (SSI), sponsored by Uji Takeda Hospital. Started May 2024; status: completed.
02
Drugs
ampicillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06368102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368102.